key: cord-0801854-fkslitj3 authors: Chen, Xin; Kozhaya, Lina; Wang, Chuxi; Placek, Lindsey; Karhan, Ece; Unutmaz, Derya title: Modulation of glucose metabolism by 2-Deoxy-D-Glucose (2DG) promotes IL-17 producing human T cell subsets date: 2022-03-18 journal: bioRxiv DOI: 10.1101/2022.03.13.484135 sha: 1cc8b5fc2635b7985515a2310e7c3536a4540c20 doc_id: 801854 cord_uid: fkslitj3 Activation and differentiation of T cells are closely linked to their cellular metabolic programs. Glycolysis and mitochondrial metabolism are thought to be critical in modulating T cell function. Here we asked to what extent inhibition of glycolysis, using 2-Deoxy-D-Glucose (2DG), regulate activation, effector function, or differentiation of human T cell subsets. We found that glycolysis is required for T cell receptor (TCR) -mediated activation and proliferation of human naive CD4+ T cells but had less of an impact on memory subsets. CD4+ T cells cultured in the presence of 2DG displayed higher level of IL-17-secreting cells (Th17) from memory or in vitro differentiated naive regulatory T cell (Tregs) subsets. Moreover, the mucosal associated invariant T (MAIT) cell subset survived or expanded better and secreted higher IL-17 in the presence of 2DG. Remarkably, we found that the 2DG effect was reversed by mannose but not by glucose. Collectively, these findings suggest that 2DG could enrich IL-17 secreting human effector T cell subsets and their cellular functions. Our finding provides a framework to manipulate glycolytic pathways in human T cells in infectious diseases such as COVID19 and in enhancing cancer immunotherapy. to 110 fold in the control media. We then asked whether 2DG has differential effects in the 125 glycolytic function of naive and memory subsets by using the Seahorse glucose stress test assay. After T cell expansion in 2DG or control media for 14 days, 2DG was washed away and cells were 127 resuspended in Seahorse XF base media, and the metabolic functions were analyzed by the 2DG enhances IL-17 producing CD4+ memory subsets. We next further explored which effector T cell subsets are modulated by suppressing glycolysis. We first observed a significantly increased CD161+ and CCR6+ populations in 2DG-treated CD4+ we observed that IL-17+ subsets were increased in both CCR6+ and CD161+ populations 141 compared to cells in control media, but interestingly, there was no difference in the low glucose 142 condition ( Figure 3C ). After 2DG was removed from the culture and cells reactivated with phorbol 143 myristate acetate (PMA) and calcium ionophore (ionomycin), we determined intracellular cytokine 144 secretion in the presence of brefeldin a (GolgiStop). We found that the frequency of cells that 145 expressed not only IL-17 but also IFN , IL-4, and IL-21 were significantly increased ( Figure 3C 146 and 3D). However, no effect was seen in IL-2 and TNF production from CD4+ T cells 147 7 (Supplemental Figure 3) . Taken together, these data demonstrate that 2DG-treatment can 148 modify the cytokine production of lineage-committed cells in long term in vitro cultures. 2DG enriches IL-17+ cells within Th17 lineage-committed CCR6+ memory T cell subset. Since we observed a significant increase in IL-17 cytokine production from 2DG-treated T cells, we hypothesized that 2DG could enhance the IL-17 production from Th17 cells compared with 152 other effector T cells. To test this hypothesis, we sorted CD4+ T cells into CCR6-and CCR6+ 153 memory T cell subsets, activated them in the presence or absence of 2DG, and expanded for two 154 weeks in IL-2, as described above ( Figure 3A) . Consistent with our prior results, 2DG-treated 155 CCR6-and CCR6+ CD4+ T cells displayed higher CD161 expression than control cells ( Figure 156 4A). IL-17 production from purified and expanded CCR6+ T cells were increased in the presence 157 of 2DG ( Figure 4B) . Notably, IFN + and IL-21+ producing CCR6+ T cells were also increased by 158 2DG (Figure 4B-E) . Interestingly, the percentage of IL-10+ and IL-17+ T cells was significantly 159 increased in 2DG-treated CCR6+ T cells (Figure 4F and 4G) . Therefore, we concluded that 2DG 160 increased CD161+ within both CCR6+ and CCR6-T cells, and also enhanced IL-17, IFN IL-21, 161 and IL-10 production from the sorted CCR6+ memory T cell subset. T cells compared to controls ( Figure 5H ). Intracellular IL-10 was also increased in HELIOS-185 population of TNregs in polarizing cytokines, and was significantly increased in HELIOS+ and 186 HELIOS-population from naive T cells ( Figure 5J ). In addition, increased cytokine production of 187 IL-17A, IL-17F, IL-10, and IFN was also confirmed by corresponding levels of cytokines detected 188 in the culture supernatants ( Figure 5K ). Taken together, 2DG enhanced the generation of IL-17-189 producing cells from both naive and TNregs, which was restricted to HELIOS-subsets. 2DG also 190 increased the production of IFN , IL-21, and IL-10 from TNregs in the polarizing condition. Kurtoglu et al., 2007) . Thus, we sought to determine 197 whether mannose can also reverse the 2DG effects on short term activation of T cells (Figure 2 ). Accordingly, we activated CD4+ naive T cells with anti-CD3/CD28 beads in media alone, with 199 3mM 2DG or mannose alone, or with 3mM 2DG supplemented with 3mM mannose. While we did Next, we asked whether mannose could reverse 2DG effects on IL-17 enrichment. After 14 days 209 cell expansion, we observed a reduction of CCR6+ and CD161+ population in a mannose-does 210 dependent manner (Figure 6F and 6G ). In addition, the 2DG mediated-reduction of IL-17, IFN , 211 and IL-21 were also reversed by mannose ( Figure 6G ). Addition of equimolar glucose into 2DG 212 culture did not reverse the 2DG-mediated enrichment of IL-17 production ( Figure 6F and 6G) . Together these findings suggest that the inhibitory effects of T cells activation and IL-17 214 production on 2DG-treated human T cells are mannose-dependent. In this study, we demonstrated that the glucose analog 2DG have remarkably different effects on 218 activation and differentiation of human T cell subsets. 2DG suppresses early human T cell 219 activation through the TCR, as assessed by cytokine production, and proliferation. However, in 220 long term cultures 2DG also profoundly increases the frequency of IL-17 production from lineage- We found that 2DG also increased the frequency of IL-17+ Tregs and IL-17 cytokine secretion Therefore, it is tempting to speculate that 2DG or similar analogs of glucose could be used to 298 modulate pathogenic responses of these T cell subsets. An increase in IL-21 production in 2DG-treated memory T cells was also shown significant in our One potential mechanism of an increase frequency of IL-17-secreting T cell subsets in 2DG-319 treated cells is that 2DG alters T cells metabolism from glucose to alternative energy sources or One of our important findings towards mechanism of action of 2DG in our system is that 2DG- Recently, 2DG has also been considered as a potential therapy during viral infections such as Jimenez 650 Moraes-652 Elevated Glucose Levels Favor SARS-CoV-2 Infection and Monocyte 653 Response through a HIF-1alpha/Glycolysis-Dependent Axis MAIT cells are imprinted by the microbiota in early life and 659 promote tissue repair Antigen Recognition by MR1-Reactive T 661 Cells; MAIT Cells, Metabolites, and Remaining Mysteries Human 666 interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor Validity of the activPAL3 activity 670 monitor in people moderately affected by Multiple Sclerosis T follicular helper cell differentiation, function, and roles in disease An interleukin-21-interleukin-675 10-STAT3 pathway is critical for functional maturation of memory CD8+ T cells PKM2 promotes Th17 cell differentiation and 680 autoimmune inflammation by fine-tuning STAT3 activation The role of IL-21 in immunity 683 and cancer Effect 685 of intestinal venous diversion on lipid metabolism Genetic polymorphisms of CXCR5 and CXCL13 are associated with non-689 responsiveness to the hepatitis B vaccine IL-21 is required to control chronic viral infection Microbiota-Dependent 695 Involvement of Th17 Cells in Murine Models of Inflammatory Arthritis IL-21 receptor signaling is integral to the development of Th2 effector responses 699 in vivo Role of Th17 Cells in the Pathogenesis of Human IBD. ISRN Inflamm The Gut Microbiota 705 Regulates Intestinal CD4 T Cells Expressing RORgammat and Controls Metabolic Single-Cell 709 The biology and functional 712 importance of MAIT cells HIV-1-infected monocyte-derived dendritic cells do not undergo maturation but can elicit 716 IL-10 production and T cell regulation Low dose of 2-deoxy-D-glucose kills 719 acute lymphoblastic leukemia cells and reverses glucocorticoid resistance via N-linked 720 glycosylation inhibition under normoxia Distinct CCR7 glycosylation pattern shapes receptor 724 signaling and endocytosis to modulate chemotactic responses Glucose uptake is limiting in T cell activation and requires CD28 -744 mediated Akt-dependent and independent pathways Decreased number and 747 impaired function of type 1 regulatory T cells in autoimmune diseases Distinct Regulation of Th17 and Th1 Cell Differentiation by 753 IL-17A-Producing Foxp3(+) Regulatory T Cells and 756 Human Diseases Signal Strength and Metabolic Requirements Control Cytokine Induced Th17 Differentiation of Uncommitted Human T Cells Circulating and gut-resident human Th17 cells express CD161 and promote 765 intestinal inflammation When worlds collide: Th17 and Treg cells in cancer and 769 autoimmunity Under normoxia, 2-deoxy-D-glucose elicits cell death 773 in select tumor types not by inhibition of glycolysis but by interfering with N-linked 774 glycosylation IL-21 receptor signalling partially mediates Th2-778 mediated allergic airway responses Induction and 782 molecular signature of pathogenic TH17 cells IL-21 Signaling in Immunity Targeting T Cell Activation and Lupus Autoimmune Phenotypes by Inhibiting Targeting LAG-3 and PD-1 to Enhance T Cell 791 Activation by Antigen-Presenting Cells Metabolic regulation of T lymphocytes Emerging roles of T helper 17 and regulatory T cells in lung cancer 800 progression and metastasis TH17 deficiency in human disease Immunomodulatory and antitumor effects of type I interferons and their application in 806 cancer therapy Differentiation of IL-17-809 producing effector and regulatory human T cells from lineage Helios enhances the 812 preferential differentiation of human fetal CD4(+) naive T cells into regulatory T cells Fatty Acid Metabolites Combine with Essential autocrine regulation by 822 IL-21 in the generation of inflammatory T cells Immune cells for microbiota surveillance 3-bromopyruvate ameliorate autoimmune arthritis by modulating Th17/Treg cell 828 differentiation and suppressing dendritic cell activation Glucose 831 metabolism regulates T cell activation, differentiation, and functions Glycolysis Is an Intrinsic Factor for 835 Fueling immunity: 837 insights into metabolism and lymphocyte function Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases Th17 lymphocytes drive vascular and neuronal deficits in a mouse model of 843 postinfectious autoimmune encephalitis A phase I dose-escalation trial of 2-deoxy-D-848 glucose alone or combined with docetaxel in patients with advanced solid tumors Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease: A 851 potential game-changer IL-854 21 in cancer immunotherapy: At the right place at the right time S(6)K(1)) in the TORC1 pathway is essential for the differentiation of Th17 Cells, 858 but not Th1, Th2, or Treg cells in mice Mitochondria are required for antigen-specific T cell activation through reactive oxygen 863 species signaling Innate mucosal-associated 867 invariant T (MAIT) cells are activated in inflammatory bowel diseases Metabolic regulation of TH17 cells Treg subpopulations are phenotypically and functionally distinct 897 and express dissimilar TCR repertoires Human RORgammat+ TH17 cells 900 preferentially differentiate from naive FOXP3+Treg in the presence of lineage-specific 901 polarizing factors Metabolic switching and fuel choice during T-cell 904 differentiation and memory development Interplay 908 between the human gut microbiome and host metabolism A 911 fundamental role for interleukin-21 in the generation of T follicular helper cells Cytokine signals through PI-3 kinase pathway modulate Th17 915 cytokine production by CCR6+ human memory T cells Production of IL-17 by 918 MAIT Cells Is Increased in Multiple Sclerosis and Is Associated with Expression Insight Into Non-Pathogenic Th17 Cells in Autoimmune 921 The wonders of 2-deoxy-D-glucose The induction and function 927 of the anti-inflammatory fate of TH17 cells Small molecule screening identified cepharanthine as an inhibitor of 931 porcine reproductive and respiratory syndrome virus infection in vitro by suppressing RACK1/PKCalpha/NF-kappaB signalling axis Satb1 regulates the effector program 936 of encephalitogenic tissue Th17 cells in chronic inflammation Type 1 regulatory T cells: a new mechanism of 939 peripheral immune tolerance IL-6 programs T(H)-17 cell differentiation by promoting sequential 943 engagement of the IL-21 and IL-23 pathways